Centiva Capital »

Takeda Pharmaceutical shares owned by Centiva Capital

Quarter-by-quarter ownership of Takeda Pharmaceutical (TAK) shares owned by Centiva Capital from 13F filings

Historical chart of Centiva Capital investment in Takeda Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Takeda Pharmaceutical held by Centiva Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Takeda Pharmaceutical by Centiva Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $265k 19k 14.22

More positions owned by Centiva Capital

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Iboxx Inv Cp Etf Call Option (LQD)
Ishares Tr 7-10 Yr Trsy Bd Put Option (IEF)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Ishares Tr National Mun Etf (MUB)
Agnc Invt Corp Com reit (AGNC)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Boeing Company Call Option (BA)
Meta Platforms Cl A (META)
Advanced Micro Devices (AMD)
Ishares Tr Russell 2000 Etf (IWM)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Centiva Capital

Top funds holding Takeda Pharmaceutical

Capital Research Global Investors
Mondrian Investment Partners
Morgan Stanley
Arrowstreet Capital, Limited Partnership
Goldman Sachs Group
Renaissance Technologies
First Trust Advisors
Brandes Investment Partners
Van Eck Associates Corp.
BlackRock
Citadel Advisors
Northern Trust
Managed Asset Portfolios
Envestnet Asset Management
BlackRock

View all funds holding Takeda Pharmaceutical